share_log
Moomoo 24/7 ·  Apr 5 12:53
Theramex Says Currently Considering CMA's Decision, In Particular Whether And How Best To Address Competition Concerns Regarding Deal With Viatris; " Co Remains Committed To Offering Women Choice To Make Empowered Decisions About HRT At Competitive Prices For NHS"; Phase 1 Of CMA's Decision To Have No Impact On Co's Ability To Supply Existing HRT Products In UK
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment